Home / BGLC : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does BGLC make money? Does BGLC have pricing power? What's the Earnings Whisper? Will BGLC profit more as the business scales? What is BGLC's management track record? Is BGLC's current price justified?

BioNexus Gene Lab Corp.

$1.61 -$2.33 (-59.14%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$1.48

Day Range

$1.54$1.61

Year Range

$1.07$6.1

Market Cap

3.89M

AVG Volume

73.47K

Trailing/Forward PE

-1.28/-

PEG ratio

-0.12

Dividend Yield

Next Earnings Date

Primary Exchange

NASDAQ

Revenue (USD)

BGLC Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	76.16K
26 Q1	22.84K
25 Q4	483.76K
25 Q3	2.54M
25 Q2	2.26M
25 Q1	2.14M
24 Q4	2.52M
24 Q3	2.63M
24 Q2	1.97M
24 Q1	2.38M

Net Income (USD)

BGLC Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-286.45K
26 Q1	-543.58K
25 Q4	-1.04M
25 Q3	-708.99K
25 Q2	-616.17K
25 Q1	-623.33K
24 Q4	-348.32K
24 Q3	-1.35M
24 Q2	199.1K
24 Q1	-103.76K

Operating Income (USD)

BGLC Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-282.4K
26 Q1	-571.43K
25 Q4	-1.03M
25 Q3	-702.51K
25 Q2	-611.29K
25 Q1	-618.42K
24 Q4	-416.22K
24 Q3	-1.34M
24 Q2	259.17K
24 Q1	-79.03K

EBITDA (USD)

BGLC EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-286.45K
26 Q1	-496.61K
25 Q4	-989.65K
25 Q3	-665.64K
25 Q2	-569.56K
25 Q1	-546.92K
24 Q4	-373.19K
24 Q3	-1.29M
24 Q2	290.62K
24 Q1	-49.44K

Cash Flows (USD)

BGLC Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-443.75K
26 Q1	-148K
25 Q4	960.09K
25 Q3	-1.24M
25 Q2	-759.37K
25 Q1	-833.12K
24 Q4	-58.34K
24 Q3	-1.62M
24 Q2	-674.11K
24 Q1	-59.1K

EPS (USD)

BGLC EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.12
26 Q1	-0.22
25 Q4	-0.53
25 Q3	-0.39
25 Q2	-0.34
25 Q1	-0.35
24 Q4	-0.19
24 Q3	-0.75
24 Q2	0.11
24 Q1	-0.06

Expenses (USD)

BGLC Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	369.48K
26 Q1	549.03K
25 Q4	1.02M
25 Q3	-85.52K
25 Q2	1.16M
25 Q1	-127.63K
24 Q4	520.93K
24 Q3	2.33M
24 Q2	769.69K
24 Q1	503.08K

Cash & Debt (USD)

BGLC Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	3.52M
26 Q1	3.96M
25 Q4	2.38M
25 Q3	2.89M
25 Q2	3.06M
25 Q1	3.6M
24 Q4	4.38M
24 Q3	4.14M
24 Q2	5.41M
24 Q1	5.83M

Debt ratios

BGLC Debt ratios by quarter
Period	Debt ratios
26 Q2	1.36
26 Q1	1.38
25 Q4	0.8
25 Q3	1.26
25 Q2	1.03
25 Q1	1.77
24 Q4	2.93
24 Q3	5.14
24 Q2	2.63
24 Q1	2.28

Margins

BGLC Margins by quarter
Period	Margins
26 Q2	17.05%
26 Q1	-99.51%
25 Q4	-0.82%
25 Q3	14.85%
25 Q2	16.28%
25 Q1	16.07%
24 Q4	12.25%
24 Q3	12.41%
24 Q2	14.62%
24 Q1	15.33%

Return on Capital

BGLC Return on Capital by quarter
Period	Return on Capital
26 Q2	-3.68%
26 Q1	-6.72%
25 Q4	-12.03%
25 Q3	-10.4%
25 Q2	-8.19%
25 Q1	-8.02%
24 Q4	-4.19%
24 Q3	-14.33%
24 Q2	2.09%
24 Q1	-1.11%

Shares Outstanding

BGLC Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	2.42M
26 Q1	2.42M
25 Q4	1.86M
25 Q3	1.8M
25 Q2	1.8M
25 Q1	1.8M
24 Q4	1.8M
24 Q3	1.8M
24 Q2	1.77M
24 Q1	1.77M

Book Value Per Share (USD)

BGLC Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	3.22
26 Q1	3.35
25 Q4	4.64
25 Q3	3.79
25 Q2	4.19
25 Q1	4.33
24 Q4	4.63
24 Q3	5.23
24 Q2	5.4
24 Q1	5.29

Total Assets (USD)

BGLC Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	8.73M
26 Q1	21.2M
25 Q4	9.25M
25 Q3	7.62M
25 Q2	9.42M
25 Q1	9.48M
24 Q4	10.43M
24 Q3	11M
24 Q2	11.14M
24 Q1	11.16M

Employee Count

BGLC Employee Count by quarter
Period	Employee Count
2025	3
2024	21
2023	18
2022	18
2021	19
2020	99
2019	55

PE Ratio

BGLC PE Ratio by quarter
Period	PE Ratio
Nov 22	680.64
Nov 22	654.46
Oct 22	667.55
Oct 22	664.27
Oct 22	667.55
Oct 22	667.55
Sep 22	694.27
Sep 22	766.26
Aug 22	759.72
Aug 22	454.37
Aug 22	454.37
Jul 22	374.38
Jul 22	390.31
Jun 22	454.37
Jun 22	450.39
Jun 22	482.25
Jun 22	498.18
Jun 22	502.17
May 22	474.29
May 22	597.75
May 22	366.97
May 22	355.58
Apr 22	373.8
Apr 22	312.29
Apr 22	380.64
Apr 22	392.03
Apr 22	150.81
Mar 22	155.25
Mar 22	152.59
Mar 22	157.91
Mar 22	166.77
Feb 22	174.75
Feb 22	159.68
Feb 22	170.32
Feb 22	153.47
Jan 22	144.61
Jan 22	161.45
Jan 22	188.94
Jan 22	176.53
Dec 21	188.94
Dec 21	168.55
Dec 21	172.98
Dec 21	172.98
Nov 21	168.55
Nov 21	176.78
Nov 21	183.19
Oct 21	173.12
Oct 21	174.03
Oct 21	109.94
Oct 21	108.11
Sep 21	108.11
Sep 21	93.39
Sep 21	107.2
Sep 21	122.76
Sep 21	128.25
Aug 21	138.33
Aug 21	141.07
Aug 21	144.74
Aug 21	160.3
Jul 21	110.05
Jul 21	164.09
Jul 21	165.04
Jul 21	176.42
Jul 21	154.61
Jun 21	155.56
Jun 21	94.81
Jun 21	174.52
Jun 21	182.11
May 21	113.85
May 21	75.5
Apr 21	81.21
Apr 21	81.21
Apr 21	44.9
Mar 21	85.69
Mar 21	183.57
Mar 21	183.57
Mar 21	174.83
Mar 21	152.99
Feb 21	183.57
Feb 21	174.83
Feb 21	174.83
Feb 21	183.57
Jan 21	201.05
Jan 21	200.17
Jan 21	201.05
Jan 21	192.31

Free Cash Flow Yield

BGLC Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-22.37%
Sep 26	-24.83%
Aug 26	-23.23%
Aug 26	-22.65%
Aug 26	-22.93%
Aug 26	-29.92%
Jul 26	-37.17%
Jul 26	-32.49%
Jul 26	-29.56%
Jul 26	-27.11%
Jul 26	-24.17%
Jun 26	-23.7%
Jun 26	-18.8%
Jun 26	-22.93%
Jun 26	-22.3%
May 26	-21.15%
May 26	-24.29%
May 26	-24.29%
May 26	-48.92%
May 26	-48.45%
Apr 26	-45.4%
Apr 26	-45.81%
Apr 26	-73.78%
Apr 26	-72.78%
Mar 26	-68.44%
Mar 26	-65.92%
Mar 26	-71.8%
Mar 26	-64.33%
Feb 26	-59.13%
Feb 26	-66.19%
Feb 26	-75.16%
Feb 26	-76.23%
Jan 26	-61.86%
Jan 26	-51.55%
Jan 26	-44.19%
Jan 26	-40.82%
Jan 26	-40.82%
Dec 25	-38.85%
Dec 25	-38.02%
Dec 25	-38.76%
Dec 25	-39.13%
Nov 25	-35.43%
Nov 25	-36.06%
Nov 25	-35.5%
Nov 25	-35.79%
Oct 25	-33.61%
Oct 25	-35.79%
Oct 25	-35.51%
Oct 25	-35.1%
Oct 25	-34.44%
Sep 25	-32.25%
Sep 25	-33.93%
Sep 25	-33.55%
Sep 25	-36.15%
Aug 25	-32.07%
Aug 25	-32.36%
Aug 25	-33.23%
Aug 25	-31.85%
Aug 25	-27.42%
Jul 25	-36.21%
Jul 25	-34.79%
Jul 25	-34.86%
Jul 25	-27.59%
Jun 25	-64.05%
Jun 25	-61.82%
Jun 25	-64.28%
Jun 25	-57.23%
May 25	-41.36%
May 25	-60.35%
May 25	-62.25%
May 25	-49.88%
May 25	-49.51%
Apr 25	-46.24%
Apr 25	-48.78%
Apr 25	-51.87%
Apr 25	-58.05%
Mar 25	-54.57%
Mar 25	-47.87%
Mar 25	-38.98%
Mar 25	-36.97%
Feb 25	-41.59%
Feb 25	-38.87%
Feb 25	-36.77%
Feb 25	-35.43%
Jan 25	-33.52%
Jan 25	-38.65%
Jan 25	-36.09%
Jan 25	-41.72%
Jan 25	-29.59%
Dec 24	-51.09%
Dec 24	-59.57%
Dec 24	-52.47%
Dec 24	-46.88%
Nov 24	-59.06%
Nov 24	-46.88%
Nov 24	-45.47%
Nov 24	-5.99%
Nov 24	-5.58%
Oct 24	-5.61%
Oct 24	-5.67%

Price to Sales

BGLC Price to Sales by quarter
Period	Price to Sales
Sep 26	1.24
Sep 26	1.12
Aug 26	1.2
Aug 26	1.23
Aug 26	1.21
Aug 26	0.75
Jul 26	0.6
Jul 26	0.69
Jul 26	0.76
Jul 26	0.82
Jul 26	0.92
Jun 26	0.94
Jun 26	1.19
Jun 26	0.97
Jun 26	1
May 26	1.06
May 26	0.92
May 26	0.92
May 26	0.52
May 26	0.52
Apr 26	0.56
Apr 26	0.55
Apr 26	0.41
Apr 26	0.42
Mar 26	0.45
Mar 26	0.46
Mar 26	0.43
Mar 26	0.47
Feb 26	0.52
Feb 26	0.46
Feb 26	0.41
Feb 26	0.4
Jan 26	0.49
Jan 26	0.59
Jan 26	0.69
Jan 26	0.75
Jan 26	0.75
Dec 25	0.79
Dec 25	0.8
Dec 25	0.79
Dec 25	0.78
Nov 25	0.86
Nov 25	0.85
Nov 25	0.86
Nov 25	0.96
Oct 25	1.02
Oct 25	0.96
Oct 25	0.96
Oct 25	0.98
Oct 25	1
Sep 25	1.06
Sep 25	1.01
Sep 25	1.02
Sep 25	0.95
Aug 25	1.07
Aug 25	1.06
Aug 25	1.04
Aug 25	1.08
Aug 25	1.25
Jul 25	0.95
Jul 25	0.99
Jul 25	0.99
Jul 25	1.25
Jun 25	0.54
Jun 25	0.56
Jun 25	0.54
Jun 25	0.6
May 25	0.83
May 25	0.57
May 25	0.55
May 25	0.49
May 25	0.5
Apr 25	0.53
Apr 25	0.51
Apr 25	0.49
Apr 25	0.44
Mar 25	0.47
Mar 25	0.54
Mar 25	0.66
Mar 25	0.69
Feb 25	0.62
Feb 25	0.66
Feb 25	0.7
Feb 25	0.72
Jan 25	0.77
Jan 25	0.66
Jan 25	0.71
Jan 25	0.62
Jan 25	0.87
Dec 24	0.5
Dec 24	0.43
Dec 24	0.49
Dec 24	0.55
Nov 24	0.43
Nov 24	0.55
Nov 24	0.56
Nov 24	0.64
Nov 24	0.68
Oct 24	0.68
Oct 24	0.67

EV/EBITDA

BGLC EV/EBITDA by quarter
Period	EV/EBITDA
Nov 23	23.97
Nov 23	23.97
Nov 23	32.19
Oct 23	31.98
Oct 23	33.34
Oct 23	55.4
Oct 23	62.9
Sep 23	80.17
Sep 23	87.46
Sep 23	91.62
Sep 23	108.27
Sep 23	153.03
Aug 23	124.93
Aug 23	78.09
Aug 23	99.95
Aug 23	184.25
Jul 23	301.86
Jul 23	608.88
Jul 23	1339.5
Jul 23	526.66
Jun 23	265.43
Jun 23	589.11
Jun 23	272.71
Jun 23	336.2
Jun 23	190.49
May 23	376.79
May 23	501.68
May 23	401.77
May 23	307.06
Apr 23	399.69
Apr 23	401.77
Apr 23	689.02
Apr 23	651.55
Mar 23	664.04
Mar 23	801.42
Mar 23	788.93
Mar 23	314.34
Feb 23	632.82
Feb 23	626.57
Jan 23	1238.55
Jan 23	1113.65
Jan 23	1251.04
Dec 22	1176.1
Dec 22	1176.1
Dec 22	1213.57
Dec 22	888.85
Nov 22	307.78
Nov 22	295.85
Oct 22	301.82
Oct 22	300.32
Oct 22	301.82
Oct 22	301.82
Sep 22	313.99
Sep 22	346.78
Aug 22	343.8
Aug 22	222.94
Aug 22	222.94
Jul 22	183.34
Jul 22	191.23
Jun 22	222.94
Jun 22	220.97
Jun 22	236.75
Jun 22	244.64
Jun 22	246.61
May 22	232.81
May 22	293.94
May 22	235.18
May 22	227.83
Apr 22	239.6
Apr 22	199.88
Apr 22	244.01
Apr 22	251.36
Apr 22	117.9
Mar 22	121.39
Mar 22	119.29
Mar 22	123.48
Mar 22	130.45
Feb 22	136.72
Feb 22	124.87
Feb 22	133.24
Feb 22	119.99
Jan 22	113.02
Jan 22	126.26
Jan 22	147.87
Jan 22	138.11
Dec 21	147.87
Dec 21	131.84
Dec 21	135.33
Dec 21	135.33
Nov 21	131.84
Nov 21	142.67
Nov 21	147.86
Oct 21	139.7
Oct 21	140.44
Oct 21	88.5
Oct 21	87.02
Sep 21	87.02
Sep 21	75.08
Sep 21	86.28
Sep 21	98.89

Price/Operating Cashflow

BGLC Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Aug 24	21.01
Aug 24	23.3
Jul 24	23.84
Jul 24	25.15
Jul 24	24.67
Jul 24	22.62
Jun 24	23.15
Jun 24	22.57
Jun 24	21.55
Jun 24	27.1
May 24	20.72
Nov 23	8.4
Nov 23	8.4
Nov 23	10.41
Oct 23	10.35
Oct 23	10.69
Oct 23	16.08
Oct 23	17.91
Sep 23	22.13
Sep 23	23.91
Sep 23	24.93
Sep 23	29
Sep 23	39.94
Aug 23	33.07
Aug 23	21.62
Aug 23	26.97
Aug 23	47.57
Jul 23	76.32
Jul 23	151.37
Jul 23	329.97
Jul 23	131.28
Jun 23	67.42
Jun 23	146.54
Jun 23	69.2
Jun 23	84.72
Jun 23	49.1
May 23	94.64
May 23	125.17
May 23	100.75
May 23	77.6
Apr 23	100.24
Apr 23	100.75
Apr 23	170.96
Apr 23	161.81
Mar 23	164.86
Mar 23	198.44
Mar 23	195.39
Mar 23	79.38
Feb 23	157.23
Feb 23	155.7
Jan 23	305.29
Jan 23	274.76
Jan 23	308.35
Dec 22	290.03
Dec 22	290.03
Dec 22	299.19
Dec 22	219.81
Nov 22	312.16
Nov 22	300.16
Oct 22	306.16
Oct 22	304.66
Oct 22	306.16
Oct 22	306.16
Sep 22	318.42
Sep 22	351.43
Aug 22	348.43
May 22	30106.29
May 22	29171.8
Apr 22	30666.99
Apr 22	25620.72
Apr 22	31227.68
Apr 22	32162.18
Apr 22	1213.12
Mar 22	1248.78
Mar 22	1227.39
Mar 22	1270.18
Mar 22	1341.51
Feb 22	1405.7
Feb 22	1284.45
Feb 22	1370.04
Feb 22	1234.52
Jan 22	1163.19
Jan 22	1298.71
Jan 22	1519.82
Jan 22	1419.96
Dec 21	1519.82
Dec 21	1355.77
Dec 21	1391.43
Dec 21	1391.43
Nov 21	1355.77
Nov 21	486.93
Nov 21	504.59
Oct 21	476.85
Oct 21	479.37
Oct 21	302.84
Oct 21	297.79
Sep 21	297.79
Sep 21	257.23
Sep 21	295.27
Sep 21	338.14

Price to Book

BGLC Price to Book by quarter
Period	Price to Book
Sep 26	0.5
Sep 26	0.45
Aug 26	0.48
Aug 26	0.49
Aug 26	0.49
Aug 26	0.49
Jul 26	0.39
Jul 26	0.45
Jul 26	0.5
Jul 26	0.54
Jul 26	0.61
Jun 26	0.62
Jun 26	0.78
Jun 26	0.64
Jun 26	0.66
May 26	0.69
May 26	0.6
May 26	0.6
May 26	0.44
May 26	0.45
Apr 26	0.48
Apr 26	0.47
Apr 26	0.57
Apr 26	0.58
Mar 26	0.62
Mar 26	0.64
Mar 26	0.59
Mar 26	0.66
Feb 26	0.72
Feb 26	0.64
Feb 26	0.56
Feb 26	0.56
Jan 26	0.69
Jan 26	0.82
Jan 26	0.96
Jan 26	1.04
Jan 26	1.04
Dec 25	1.09
Dec 25	1.11
Dec 25	1.09
Dec 25	1.08
Nov 25	1.2
Nov 25	1.18
Nov 25	1.19
Nov 25	1.22
Oct 25	1.29
Oct 25	1.22
Oct 25	1.23
Oct 25	1.24
Oct 25	1.26
Sep 25	1.35
Sep 25	1.28
Sep 25	1.3
Sep 25	1.2
Aug 25	1.36
Aug 25	1.34
Aug 25	1.23
Aug 25	1.29
Aug 25	1.5
Jul 25	1.13
Jul 25	1.18
Jul 25	1.18
Jul 25	1.49
Jun 25	0.64
Jun 25	0.66
Jun 25	0.64
Jun 25	0.72
May 25	0.99
May 25	0.68
May 25	0.66
May 25	0.58
May 25	0.58
Apr 25	0.62
Apr 25	0.59
Apr 25	0.5
Apr 25	0.45
Mar 25	0.48
Mar 25	0.55
Mar 25	0.67
Mar 25	0.71
Feb 25	0.63
Feb 25	0.67
Feb 25	0.71
Feb 25	0.74
Jan 25	0.78
Jan 25	0.68
Jan 25	0.72
Jan 25	0.63
Jan 25	0.88
Dec 24	0.51
Dec 24	0.44
Dec 24	0.5
Dec 24	0.56
Nov 24	0.44
Nov 24	0.56
Nov 24	0.57
Nov 24	0.65
Nov 24	0.7
Oct 24	0.69
Oct 24	0.69

No video analysis for this stock yet. Request one from our team.

News: BGLC

globenewswire.com · 28 Jul 2026

BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit

KUALA LUMPUR, Malaysia, July 28, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) ("BioNexus" or the "Company") today announced continued progress toward commercializing the VitaGuard™ molecular residual disease ("MRD") platform in Southeast Asia following a recent working visit to facilities of the Tongshu Gene group ("Tongshu Gene") in Shanghai and Changzhou, China, led by Dr. Muthu Meyyappan, Chief Commercial Officer of Fidelion Diagnostics Pte. Ltd. ("Fidelion").

AI Analysis

BioNexus Gene Lab Corp.

Video analysis: BGLC

News: BGLC

BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit

Similar companies